Article info

PDF
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor

Authors

  1. Correspondence to Dr Karmela Kim Chan, Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, New York, NY 10021, USA; chanka{at}hss.edu
View Full Text

Citation

Chan KK, Bass AR
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor

Publication history

  • Received April 28, 2018
  • Accepted April 30, 2018
  • First published May 14, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.